TD Asset Management Inc Has $14.82 Million Stock Holdings in The Clorox Company $CLX

Key Points

• TD Asset Management Inc reduced its holdings in The Clorox Company by 31.9% in Q2, now owning approximately 123,453 shares, valued at about $14.82 million.
• Clorox reported $2.87 earnings per share (EPS) for the last quarter, exceeding analyst expectations, with a revenue of $1.99 billion, up 4.5% year-over-year.
• The firm recently declared a quarterly dividend of $1.24 per share, yielding around 4.1%, set to be paid on November 6th.

TD Asset Management Inc cut its holdings in The Clorox Company (NYSE:CLX - Free Report) by 31.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 123,453 shares of the company's stock after selling 57,702 shares during the quarter. TD Asset Management Inc owned about 0.10% of Clorox worth $14,823,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. American National Bank & Trust lifted its stake in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company's stock worth $26,000 after buying an additional 89 shares during the last quarter. Ransom Advisory Ltd acquired a new stake in shares of Clorox in the first quarter worth $35,000. GW&K Investment Management LLC lifted its stake in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after buying an additional 208 shares during the last quarter. Ameritas Advisory Services LLC acquired a new stake in shares of Clorox in the second quarter worth $48,000. Finally, Roble Belko & Company Inc lifted its stake in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock worth $53,000 after buying an additional 211 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 1.8%

Shares of Clorox stock opened at $119.73 on Friday. The firm has a market capitalization of $14.58 billion, a PE ratio of 18.36, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company's fifty day moving average price is $121.61 and its two-hundred day moving average price is $127.73. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox's payout ratio is 76.07%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company's stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.63% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CLX. Citigroup reduced their price objective on shares of Clorox from $135.00 to $130.00 and set a "neutral" rating for the company in a research note on Wednesday, October 8th. UBS Group reduced their price objective on shares of Clorox from $134.00 to $128.00 and set a "neutral" rating for the company in a research note on Wednesday, October 8th. The Goldman Sachs Group cut their target price on shares of Clorox from $115.00 to $110.00 and set a "sell" rating for the company in a research note on Wednesday, October 1st. Weiss Ratings reiterated a "hold (c-)" rating on shares of Clorox in a research note on Tuesday, October 14th. Finally, Wells Fargo & Company cut their target price on shares of Clorox from $130.00 to $125.00 and set an "equal weight" rating for the company in a research note on Thursday, September 25th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Reduce" and an average target price of $130.20.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.